Clinical and Economic Impact of Duodopa: Long-term Effectiveness Study in Advanced Parkinson's Disease Patients
- Registration Number
- NCT01291537
- Lead Sponsor
- Poitiers University Hospital
- Brief Summary
The goal of this multicentric prospective randomized controlled clinical and economic study is to investigate the effectiveness and cost-utility of long-term continuous intraduodenal infusion of levodopa ( DUODOPA), compared to best medical treatment, on advanced and severe form of Parkinson's disease.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 56
Inclusion Criteria
Not provided
Exclusion Criteria
- Age <18 and> 80 years
- No signature of the informed consent form
- Patient with no social insurance or who cannot benefit it through a third person in accordance with the French law on biomedical research
- Population under enhanced protection (i.e minors), pregnant women, breast-feeding women, persons deprived of their liberty by a judicial or administrative decision, people in health and social service, adults under legal protection, and finally patients in emergency situations.
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- Not specified
- Arm && Interventions
Group Intervention Description Duodopa Duodopa - Best medical treatment best médical treatment -
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (20)
CH d'Aix en Provence
🇫🇷Aix en Provence, France
Chu Amiens
🇫🇷Amiens, France
Chu Clermont-Ferrand
🇫🇷Clermont-ferrand, France
Hôpital Henri Mondor
🇫🇷Creteil, France
Chu Lille
🇫🇷Lille, France
Chu de Limoges
🇫🇷Limoges, France
Chu de Lyon
🇫🇷Lyon, France
Chu de Marseille
🇫🇷Marseille, France
Chu de Nantes
🇫🇷Nantes, France
Chu de Nice
🇫🇷Nice, France
Scroll for more (10 remaining)CH d'Aix en Provence🇫🇷Aix en Provence, France